|  ﻿drug_name  | mechanism_of_action  | experimental_activity  | experimental_pharmacology_system  | method  | parameter  | PX  | mean  | unit  | 
| ---- | --- | --- | --- | --- | --- | --- | --- | --- | 
|  Oseltamivir carboxylate  | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors  | Neuraminidase (nonspecified subtype) (Influenza A virus) inhibition, IN VITRO  | IN VITRO  | Fluorescent assay  | IC-50  | 12.69897  | 2.00E-13  | M  | 
|  Presatovir  | Respiratory Syncytial Virus (RSV) Fusion Inhibitors;Viral Fusion Inhibitors  | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO  | IN VITRO  | Cytopathicity assay  | IC-50  | 11.74472749  | 1.80E-12  | M  | 
|  Brincidofovir  | DNA Polymerase Inhibitors  | Infection, cytomegalovirus remission/reduction, IN VITRO  | IN VITRO  | DNA assay  | IC-50  | 11.69897  | 2.00E-12  | M  | 
|  Sorivudine  | DNA Polymerase Inhibitors  | Infection, varicella zoster virus remission/reduction, IN VITRO  | IN VITRO  | Plaque assay  | IC-50  | 10.61978876  | 2.40E-11  | M  | 
|  Peramivir  | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors  | Neuraminidase (nonspecified subtype) (Influenza A virus) inhibition, IN VITRO  | IN VITRO  | 4-Methylumbelliferyl-N-acetyl-alpha-D-neuraminic acid as substrate  | Ki  | 10.85387196  | 1.40E-11  | M  | 
|  Zanamivir  | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors  | Neuraminidase (nonspecified subtype) (Influenza A virus) inhibition, IN VITRO  | IN VITRO  | Chemiluminescent assay  | IC-50  | 10.52287875  | 3.00E-11  | M  | 
|  Sirolimus  | CCR5 Expression Inhibitors;Cytochrome P450 CYP2D6 Inhibitors;Signal Transduction Modulators;Cytochrome P450 CYP2C9 Inhibitors;P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Proteasome Inhibitors;Mammalian Target of Rapamycin (mTOR; FRAP1) Inhibitors;Drugs Targeting B-Lymphocyte Antigen CD19  | Infection, cytomegalovirus remission/reduction, IN VITRO  | IN VITRO  | Chemiluminescent assay  | IC-50  | 10.39794001  | 4.00E-11  | M  | 
|  Peramivir  | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors  | Neuraminidase (nonspecified subtype) (Influenza A virus) inhibition, IN VITRO  | IN VITRO  | 4-Methylumbelliferyl-N-acetyl-alpha-D-neuraminic acid as substrate  | IC-50  | 10.30103  | 5.00E-11  | M  | 
|  Laninamivir  | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors  | Neuraminidase (nonspecified subtype) (Influenza A virus) inhibition, IN VITRO  | IN VITRO  | Fluorescent assay  | IC-50  | 9.958607315  | 1.10E-10  | M  | 
|  Ribavirin  | Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Equilibrative Nucleoside Transporter ENT1 Inhibitors  | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO  | IN VITRO  | ELISA assay  | IC-50  | 9.899629455  | 1.26E-10  | M  | 


|  ﻿drug_name  | mechanism_of_action  | experimental_activity  | experimental_pharmacology_system  | method  | parameter  | PX  | mean  | unit  | 
| ---- | --- | --- | --- | --- | --- | --- | --- | --- | 
|  Deferiprone  | Chelating Agents;Cytochrome P450 CYP4F2 Inhibitors  | Infection, BK polyomavirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 8.455931956  | 3.50E-09  | M  | 
|  Raltegravir potassium  | HIV Integrase Inhibitors  | Infection, xenotropic murine leukemia virus-related virus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 8.301029996  | 0.000000005  | M  | 
|  Verdinexor  | Exportin-1 (CRM1, XPO1) Receptor Antagonists;Signal Transduction Modulators  | Infection, JC polyomavirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 8.124938737  | 7.50E-09  | M  | 
|  Rupintrivir  | HRV 3C Protease Inhibitors  | Infection, rhinovirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.698970004  | 0.00000002  | M  | 
|  Brincidofovir  | DNA Polymerase Inhibitors  | Infection, JC polyomavirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.698970004  | 0.00000002  | M  | 
|  Remdesivir  | Nucleobindin-1 (NUCB1) Inhibitors  | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.602059991  | 0.000000025  | M  | 
|  Verdinexor  | Exportin-1 (CRM1, XPO1) Receptor Antagonists;Signal Transduction Modulators  | Infection, adenovirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.522878745  | 0.00000003  | M  | 
|  Torin-1  | Phosphatidylinositol 3-Kinase alpha (PI3Kalpha) Inhibitors;Signal Transduction Modulators;Mammalian Target of Rapamycin (mTOR; FRAP1) Inhibitors  | Infection, cytomegalovirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.22184875  | 0.00000006  | M  | 
|  Cidofovir  | DNA Polymerase Inhibitors  | Infection, cytomegalovirus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-99  | 7.22184875  | 0.00000006  | M  | 
|  Alvocidib hydrochloride  | Cyclin-Dependent Kinase 1 (CDK1) Inhibitors;Signal Transduction Modulators;Cyclin-Dependent Kinase 6 (CDK6) Inhibitors;CDK9/Cyclin T1 Inhibitors;Baculoviral IAP Repeat-Containing Protein 5 (BIRC5; Survivin) Inhibitors;Apoptosis Inducers;Cyclin-Dependent Kinase 7 (CDK7) Inhibitors;Cyclin-Dependent Kinase 2 (CDK2) Inhibitors;Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Inhibitors;Cyclin-Dependent Kinase 4 (CDK4) Inhibitors;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors;Apoptosis Regulator Bcl-2 Inhibitors  | Infection, herpes virus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7.000217202  | 1.00E-07  | M  | 
|  Ganciclovir  | DNA Polymerase Inhibitors  | Infection, herpes simplex virus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 7  | 0.0000001  | M  | 



|  ﻿drug_name  | mechanism_of_action  | experimental_activity  | experimental_pharmacology_system  | method  | parameter  | PX  | mean  | unit  | 
| ---- | --- | --- | --- | --- | --- | --- | --- | --- | 
|  Remdesivir  | RNA-Directed RNA Polymerase Inhibitor  | Ebola virus disease remission/reduction, IN VITRO  | IN VITRO  |   | IC-50  | 8  | 0.00000001  | M  | 
|  Inarigivir soproxil  | Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Activators;Probable ATP-dependent RNA helicase DDX58 (RIG-I) Activators  | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO  | IN VITRO  | Plaque assay  | IC-80  | 6.602059991  | 0.00000025  | M  | 
|  Lumicitabine  | RNA-Directed RNA Polymerase (Respiratory Syncytial Virus) Inhibitors  | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 6.585026652  | 0.00000026  | M  | 
|  Sofosbuvir  | RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IN VITRO  | Plaque assay  | IC-90  | 6.397940009  | 0.0000004  | M  | 
|  Adafosbuvir  | RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IN VITRO  | Plaque assay  | IC-50  | 5.958607315  | 0.0000011  | M  | 
|  Balapiravir hydrochloride  | RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay  | IC-50  | 5.721246399  | 0.0000019  | M  | 
|  Galidesivir  | RNA Polymerase Inhibitors  | Infection, Zika virus remission/reduction, IN VITRO  | IN VITRO  | Fluorescent assay  | IC-50  | 5.528708289  | 0.00000296  | M  | 
|  Beclabuvir  | RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, herpes simplex virus remission/reduction, IN VITRO  | IN VITRO  | Viral replication assay (multiple cycle)  | IC-50  | 5.397940009  | 0.000004  | M  | 
|  Favipiravir  | RNA-Directed RNA Polymerase (Influenza A Virus H1N1) Inhibitors;RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, rabies virus remission/reduction, IN VITRO  | IN VITRO  | Fluorescent assay  | MIC  | 5.397940009  | 0.000004  | M  | 
|  Diasarone I  | RNA-Directed RNA Polymerase (NS5) (Dengue Virus) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IN VITRO  | Plaque assay  | IC-50  | 5.369572125  | 0.00000427  | M  | 
